IRIS- DESyne X2 in the IRIS-DES Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Eligibility criteria
Qualifiers
Age 19 and more
Intervention with DeSyne X2 drug-eluting coronary stent
Agreed with written informed consent form
Disqualifiers
Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
Life expectancy of 1year and under
Cardiac shock
Trial design
Treatments tested in this trial
- DESyne X2
Treatment groups
1,000 Participants
are divided into 1 treatment groupLocations
6Hallym Hospital Incheon South Korea
Asan Medical Hospital Seoul South Korea
Korea University Guro Hospital Seoul South Korea
The Catholic University of Korea Seoul St. Mary's Hospital Seoul South Korea
Sponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov